GHIT Fund Awarded Open Philanthropy Grant to Expand Funding Sources for Global Health R&D

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TOKYO, Nov. 18, 2024 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund is pleased to announce that Open Philanthropy, a grantmaking organization based in San Francisco, California, has awarded funding for efforts to cultivate new partnerships and secure resources from the private sector and individual champions for global health R&D innovation, primarily in Japan, and will join GHIT as a new sponsor.

Dr. Osamu Kunii, CEO of the GHIT Fund, said, “We truly welcome Open Philanthropy’s support to expand our capacity to secure resources for transformational global health R&D, specifically by engaging new stakeholders in our work, aligned with GHIT 3.0, our third five-year plan.”

This new support from Open Philanthropy will enable GHIT to further amplify its impact, fostering innovative collaborations and accelerating the development of life-saving global health solutions for those who need them most.

About Open Philanthropy
Open Philanthropy is a philanthropic funder whose mission is to help others as much as it can with the resources available to them. It stresses openness to many possibilities and has chosen its focus areas based on importance, neglectedness, and tractability. Open Philanthropy has concentrated on selecting focus areas in two broad categories: Global Health & Wellbeing and Global Catastrophic Risks. 
For more information, please visit https://www.openphilanthropy.org/.

About the GHIT Fund
The GHIT Fund is a Japan-based international public-private partnership (PPP) fund that was formed between the Government of Japan, multiple pharmaceutical companies, the Bill & Melinda Gates Foundation, the Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which afflict the world’s vulnerable and underserved populations. In collaboration with global partners, the GHIT Fund mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases.
https://www.ghitfund.org/en

For more information, contact:
Katy Lenard at + 1-202-494-2584 or klenard@burness.com
Mina Ohata at +81-36441-2032 or mina.ohata@ghitfund.org

View original content:https://www.prnewswire.com/news-releases/ghit-fund-awarded-open-philanthropy-grant-to-expand-funding-sources-for-global-health-rd-302307596.html

SOURCE Global Health Innovative Technology Fund (GHIT Fund)

Staff

Recent Posts

Skypoint Launches Lia and Scribe: AI-Powered Agents Redefining Clinical Workflow Efficiency and Social Determinants of Health (SDOH) Data Capture

PORTLAND, Ore., June 13, 2025 /PRNewswire/ -- Skypoint, a leading provider of HITRUST r2-certified AI platform…

5 hours ago

Prior to FIFA Club World Cup Kickoff, FC Mother and Omya Launch Landmark Joint Venture to Fund “Life Years” as Part of World Cup of Healing Legacy Project

First-of-its-kind joint venture funds longevity gains and maternal healing through football, creating a new category…

5 hours ago

Personal Safety Tracking Devices Market to Reach USD 1.6 Billion by 2030, Driven by GPS and Bluetooth Advancements | Valuates Reports

BANGALORE, India, June 13, 2025 /PRNewswire/ -- Personal Safety Tracking Devices Market is Segmented by Type…

5 hours ago

Dana Foundation Recognizes Two Neuroscience & Society Champions with Inaugural Awards

Neuroethicist and psychiatrist are recognized for innovation and transformative interdisciplinary work to advance neuroscience's benefits…

5 hours ago

Clear Guide Medical LUMENA™ Featured in SPIE Study on MRI-Guided Interventions

BALTIMORE, June 13, 2025 /PRNewswire/ -- Clear Guide Medical, a leader in AI- and AR-powered…

5 hours ago